Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Q32 Bio (QTTB) Invested Capital (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Invested Capital data on record, last reported at $48.2 million in Q4 2025.

  • For Q4 2025, Invested Capital rose 450.03% year-over-year to $48.2 million; the TTM value through Dec 2025 reached $48.2 million, up 450.03%, while the annual FY2025 figure was $48.2 million, 450.03% up from the prior year.
  • Invested Capital reached $48.2 million in Q4 2025 per QTTB's latest filing, up from -$12.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $266.3 million in Q1 2022 and bottomed at -$182.0 million in Q4 2023.
  • Average Invested Capital over 5 years is $45.2 million, with a median of $26.7 million recorded in 2024.
  • Peak YoY movement for Invested Capital: crashed 177.05% in 2022, then soared 450.03% in 2025.
  • A 5-year view of Invested Capital shows it stood at $169.7 million in 2021, then plummeted by 177.05% to -$130.7 million in 2022, then plummeted by 39.27% to -$182.0 million in 2023, then skyrocketed by 104.82% to $8.8 million in 2024, then skyrocketed by 450.03% to $48.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $48.2 million in Q4 2025, -$12.2 million in Q3 2025, and -$6.0 million in Q2 2025.